Here are four observations:
1. Mr. Lieber has more than 20 years of executive management experience at emerging life sciences companies and in investment banking.
2. Mr. Lieber most recently served as the CFO of Metamark Genetics, a privately held, urology-focused, molecular diagnostics company.
3. He has also served as the CFO and treasurer of Repligen Corporation and CFO of Xcellerex.
4. Histogenics is a regenerative medicine company focused on developing and marketing products in the musculoskeletal marketplace.
More articles on devices:
Michael Turpin joins K2M board of directors — 5 key notes
22 things to know about Stryker
FDA grants Centinel Spine allogeneic bone graft indications for lumbar spinal fusion line — 5 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
